Zhejiang Taimei Medical Technology Co., Ltd.
↗Shanghai, China
Taimei Technology is a leading Chinese digital solution provider for the life sciences industry. The company develops and delivers cloud-based software and digital services, such as their flagship TrialOS platform, designed to facilitate pharmaceutical R&D, clinical trial management, pharmacovigilance, and medical marketing.
By leveraging AI, big data, and cloud computing, Taimei connects various stakeholders—including pharmaceutical companies, CROs, hospitals, and patients—to streamline clinical research processes, improve data flow, and enhance collaboration across the entire drug development lifecycle.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:-
Industry:Digital Health
Sub-Industry:eClinical Software / SaaS
SIZE & FINANCIALS
Employees:501-1000
Founded:2013
Ownership:public
Status:operating
FUNDING
Stage:Post-IPO
Investors:Tencent Investment, Tiger Global Management, Softbank China Capital
STOCK
Exchange:HKEX
Ticker:02576
Market Cap:$2.54B
0
CORPORATE STRUCTURE
Subsidiaries:Shanghai Taimei Xinghui Investment
Key Partnerships:Serves over 1,400 pharmaceutical companies and CROs, Partnerships with approx. 700 national clinical trial institutions and 370+ SMOs
COMPETITION
Position:Leader
Competitors:LinkDoc, YIDUCLOUD
LEADERSHIP
Key Executives:
Zhao Lu - Chairman & CEO
LINKS
Website:taimei.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Zhejiang Taimei Medical Technology Co., Ltd. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Zhejiang Taimei Medical Technology Co., Ltd.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.